activins has been researched along with Edema-Proteinuria-Hypertension Gestosis in 64 studies
Activins: Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To analyse the predictive power of maternal serum inhibin A, activin A, human chorionic gonadotropin (hCG), unconjugated estriol (uE(3)), alpha-fetoprotein (AFP) levels and uterine artery Doppler in the second trimester of pregnancy in screening for pre-eclampsia." | 7.73 | Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. ( Ay, E; Elter, K; Gokaslan, H; Kavak, ZN; Pekin, T, 2005) |
| "To analyse the predictive power of maternal serum inhibin A, activin A, human chorionic gonadotropin (hCG), unconjugated estriol (uE(3)), alpha-fetoprotein (AFP) levels and uterine artery Doppler in the second trimester of pregnancy in screening for pre-eclampsia." | 3.73 | Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. ( Ay, E; Elter, K; Gokaslan, H; Kavak, ZN; Pekin, T, 2005) |
| "Preeclampsia is a major cause of maternal morbidity and mortality worldwide." | 2.44 | Novel biomarkers for predicting preeclampsia. ( Carty, DM; Delles, C; Dominiczak, AF, 2008) |
| "It is known that preeclampsia affects lactogenesis." | 1.91 | Preeclampsia and Its Impact on Human Milk Activin A Concentration. ( Barbagallo, I; Bertino, E; Coscia, A; Galvano, F; Gazzolo, D; Livolti, G; Peila, C; Riboldi, L; Sottemano, S; Spada, E, 2023) |
| "Preeclampsia is a multisystem hypertensive disorder of pregnancy that remains one of the leading causes of maternal and perinatal morbidity and mortality worldwide." | 1.72 | Activin A causes endothelial dysfunction of mouse aorta and human aortic cells. ( Barber, C; Hannan, NJ; Marshall, SA; Wallace, EM; Yap, Y, 2022) |
| "Clinical management of preeclampsia has remained unchanged for almost 5 decades." | 1.42 | Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies. ( Acharya, R; Delpachitra, P; Drummond, GR; Hobson, S; Lim, R; Sobey, CG; Wallace, EM, 2015) |
| "The pregnancy-specific disorder preeclampsia is a major cause of maternal mortality and morbidity." | 1.38 | High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling. ( Bai, Y; Cao, B; Cui, N; Fu, G; Li, D; Li, J; Li, YX; Liao, QP; Liu, M; Peng, C; Wang, H; Wang, YL; Yang, HX; Ye, G; Yu, L, 2012) |
| "In the women with preeclampsia, but not in those with a normal pregnancy, circulating levels of 8-isoprostane and activin A were significantly and positively correlated (r(2) = 0." | 1.34 | Oxidative stress increases placental and endothelial cell activin A secretion. ( Mandang, S; Manuelpillai, U; Wallace, EM, 2007) |
| "The best cut-off values for predicting preeclampsia of placental growth factor, activin A and fibronectin based on ROC curve analysis were 90 pg/ml, 14 ng/ml and 370 mg/l respectively." | 1.33 | Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. ( Kuseyrioglu, B; Madazli, R; Ocak, V; Uludag, S; Uzun, H, 2005) |
| "Preeclampsia has been shown to be associated with an increased number of fetal and maternal erythroblasts in the maternal circulation, suggesting that preeclampsia involves increased leakage of fetal cells across the placental barrier, as well as increased erythropoiesis." | 1.33 | Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies. ( Hahn, S; Holzgreve, W; Ladewig, A; Troeger, C; Zhong, XY, 2006) |
| "Those with chronic hypertension have lower serum but not urine free activin A levels, compared with severe pre-eclampsia and mild pre-eclampsia." | 1.33 | Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia. ( Buhimschi, CS; Buhimschi, IA; Copel, JA; Funai, EF; Hamar, BD; Magloire, LK; Pettker, CM; Sfakianaki, AK, 2006) |
| "Activin A is not a useful predictor of preeclampsia in this setting." | 1.32 | Maternal serum activin A is not elevated before preeclampsia in women who are at high risk. ( Blackburn, CA; Keelan, JA; North, RA; Taylor, RS, 2003) |
| "Nineteen women with preeclampsia symptoms were matched with 19 normal pregnant controls for gestational age, maternal age, and parity." | 1.32 | Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. ( Bersinger, NA; Groome, NP; Muttukrishna, S; Redman, CW; Smárason, AK, 2003) |
| "Activin A is raised in preeclampsia, suggesting a possible involvement in its pathophysiology." | 1.32 | Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia. ( Groome, NP; Muttukrishna, S; Redman, CW; Sargent, IL; Tannetta, DS, 2003) |
| "Twenty women with preeclampsia were enrolled in this study." | 1.32 | [Study on the relationship between activin A, follistatin and preeclampsia]. ( Li, H; Liu, ZH; Shang, T; Tang, S; Wang, YL; Zhao, L, 2003) |
| "Twelve patients with preeclampsia were identified and matched with 24 controls." | 1.31 | Serum levels of activin A and inhibin A and the subsequent development of preeclampsia. ( Grobman, WA; Wang, EY, 2000) |
| "Serum samples of 20 women with preeclampsia (study group) and 20 normotensive pregnant women, matched for maternal and gestational age and parity, were assayed for inhibin A, inhibin B and activin A by specific enzyme-linked immunosorbent assay." | 1.31 | Serum levels of inhibin B, unlike inhibin A and activin A, are not altered in women with preeclampsia. ( Eshed-Englender, T; Frenkel, J; Geva, E; Kupferminc, MJ; Sherman, D; Yair, D, 2001) |
| "In contrast to women with preeclampsia, normotensive women with SGA pregnancies do not have markedly elevated circulating levels of activin A and inhibin A." | 1.31 | Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. ( Groome, NP; Keelan, JA; Mitchell, MD; North, RA; Schellenberg, JC; Taylor, R, 2002) |
| "Activin A levels were higher in the preeclampsia group (median 31." | 1.30 | Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. ( Canick, JA; Hogan, J; Lambert-Messerlian, GM; Silver, HM; Star, JA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (7.81) | 18.2507 |
| 2000's | 38 (59.38) | 29.6817 |
| 2010's | 17 (26.56) | 24.3611 |
| 2020's | 4 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, GP | 1 |
| Andres, F | 1 |
| Walker, SP | 1 |
| MacDonald, TM | 1 |
| Cannon, P | 1 |
| Nguyen, TV | 1 |
| Keenan, E | 1 |
| Hannan, NJ | 2 |
| Tong, S | 2 |
| Kaitu'u-Lino, TJ | 1 |
| Barber, C | 1 |
| Yap, Y | 1 |
| Wallace, EM | 11 |
| Marshall, SA | 2 |
| Barrero, JA | 1 |
| Villamil-Camargo, LM | 1 |
| Imaz, JN | 1 |
| Arciniegas-Villa, K | 1 |
| Rubio-Romero, JA | 1 |
| Coscia, A | 1 |
| Riboldi, L | 1 |
| Spada, E | 1 |
| Bertino, E | 1 |
| Sottemano, S | 1 |
| Barbagallo, I | 1 |
| Livolti, G | 1 |
| Galvano, F | 1 |
| Gazzolo, D | 1 |
| Peila, C | 1 |
| Hobson, SR | 2 |
| Lim, R | 5 |
| Mockler, JC | 2 |
| Gurusinghe, S | 3 |
| Cox, AG | 1 |
| Rahman, R | 2 |
| Chan, ST | 2 |
| Muljadi, R | 1 |
| Singh, H | 1 |
| Leaw, B | 2 |
| Murthi, P | 2 |
| Acharya, R | 3 |
| Delpachitra, P | 1 |
| Hobson, S | 1 |
| Sobey, CG | 1 |
| Drummond, GR | 1 |
| Gangooly, S | 1 |
| Muttukrishna, S | 8 |
| Jauniaux, E | 1 |
| Williamson, RD | 1 |
| O'Keeffe, GW | 1 |
| Kenny, LC | 1 |
| Thulluru, HK | 1 |
| Michel, OJ | 1 |
| Oudejans, CB | 1 |
| van Dijk, M | 1 |
| Adhikari, S | 1 |
| Ciayadi, R | 1 |
| Potdar, M | 1 |
| Kelso, GF | 1 |
| Hearn, MT | 1 |
| Zhu, XL | 1 |
| Wang, J | 1 |
| Jiang, RZ | 1 |
| Teng, YC | 1 |
| Yong, HE | 1 |
| Wong, MH | 1 |
| Kalionis, B | 1 |
| Cartwright, JE | 1 |
| Brennecke, SP | 1 |
| Keogh, RJ | 1 |
| Wijayarathna, R | 1 |
| de Kretser, DM | 2 |
| Mockler, J | 1 |
| Xu, YT | 1 |
| Shen, MH | 1 |
| Jin, AY | 1 |
| Li, H | 3 |
| Zhu, R | 1 |
| Carty, DM | 1 |
| Delles, C | 1 |
| Dominiczak, AF | 1 |
| Spencer, K | 3 |
| Cowans, NJ | 1 |
| Nicolaides, KH | 5 |
| Reddy, A | 1 |
| Suri, S | 1 |
| Sargent, IL | 2 |
| Redman, CW | 6 |
| Akolekar, R | 1 |
| Etchegaray, A | 1 |
| Zhou, Y | 1 |
| Maiz, N | 1 |
| Yu, J | 1 |
| Shixia, CZ | 1 |
| Wu, Y | 1 |
| Duan, T | 1 |
| Huang, F | 1 |
| Shelling, AN | 1 |
| Yu, L | 1 |
| Li, D | 1 |
| Liao, QP | 1 |
| Yang, HX | 1 |
| Cao, B | 1 |
| Fu, G | 1 |
| Ye, G | 1 |
| Bai, Y | 1 |
| Wang, H | 1 |
| Cui, N | 1 |
| Liu, M | 1 |
| Li, YX | 1 |
| Li, J | 1 |
| Peng, C | 1 |
| Wang, YL | 2 |
| Lai, J | 1 |
| Pinas, A | 1 |
| Syngelaki, A | 1 |
| Poon, LC | 1 |
| Blumenstein, M | 1 |
| Mitchell, MD | 2 |
| Groome, NP | 7 |
| Keelan, JA | 3 |
| Manuelpillai, U | 3 |
| Schneider-Kolsky, M | 2 |
| Thirunavukarasu, P | 1 |
| Dole, A | 2 |
| Waldron, K | 1 |
| Davidson, EJ | 1 |
| Riley, SC | 1 |
| Roberts, SA | 1 |
| Shearing, CH | 1 |
| Martin, CW | 1 |
| Florio, P | 3 |
| Ciarmela, P | 1 |
| Luisi, S | 2 |
| Palumbo, MA | 1 |
| Lambert-Messerlian, G | 1 |
| Severi, FM | 2 |
| Petraglia, F | 4 |
| Reis, FM | 2 |
| Pezzani, I | 1 |
| Schneider-Kolsky, ME | 1 |
| Edwards, A | 1 |
| Baker, L | 1 |
| Jenkin, G | 1 |
| Blackburn, CA | 1 |
| Taylor, RS | 2 |
| North, RA | 3 |
| Bersinger, NA | 1 |
| Smárason, AK | 1 |
| Casagrandi, D | 1 |
| Bearfield, C | 1 |
| Geary, J | 1 |
| Hanisch, CG | 1 |
| Pfeiffer, KA | 1 |
| Schlebusch, H | 1 |
| Schmolling, J | 1 |
| Tannetta, DS | 1 |
| Zhao, L | 1 |
| Shang, T | 1 |
| Tang, S | 1 |
| Liu, ZH | 1 |
| Seufert, R | 1 |
| Neubert, S | 1 |
| Tanner, B | 1 |
| Schaffrath, M | 1 |
| Pollow, K | 1 |
| Kölbl, H | 1 |
| Ong, CY | 1 |
| Liao, AW | 1 |
| Munim, S | 1 |
| Rohra, DK | 1 |
| Qidwai, N | 1 |
| Madazli, R | 1 |
| Kuseyrioglu, B | 1 |
| Uzun, H | 1 |
| Uludag, S | 1 |
| Ocak, V | 1 |
| Ay, E | 1 |
| Kavak, ZN | 1 |
| Elter, K | 1 |
| Gokaslan, H | 1 |
| Pekin, T | 1 |
| Troeger, C | 1 |
| Holzgreve, W | 2 |
| Ladewig, A | 1 |
| Zhong, XY | 2 |
| Hahn, S | 2 |
| Yu, CK | 1 |
| Savvidou, M | 1 |
| Papageorghiou, AT | 1 |
| Ekbom, P | 1 |
| Damm, P | 1 |
| Andersson, AM | 1 |
| Skakkebaek, NE | 1 |
| Feldt-Rasmussen, U | 1 |
| Mathiesen, ER | 1 |
| Hyett, J | 1 |
| Paine, M | 1 |
| Moodley, J | 1 |
| Groome, N | 2 |
| Rodeck, C | 1 |
| Arai, K | 1 |
| Taya, K | 1 |
| Hamar, BD | 1 |
| Buhimschi, IA | 1 |
| Sfakianaki, AK | 1 |
| Pettker, CM | 1 |
| Magloire, LK | 1 |
| Funai, EF | 1 |
| Copel, JA | 1 |
| Buhimschi, CS | 1 |
| Diesch, CH | 1 |
| Mandang, S | 1 |
| Banzola, I | 1 |
| Farina, A | 1 |
| Concu, M | 1 |
| Sekizawa, A | 1 |
| Purwosunu, Y | 1 |
| Strada, I | 1 |
| Arcelli, D | 1 |
| Simonazzi, G | 1 |
| Caramelli, E | 1 |
| Rizzo, N | 1 |
| Aguzzoli, L | 1 |
| Gallinelli, A | 1 |
| Zonca, M | 1 |
| Benedetto, C | 2 |
| Woodruff, K | 1 |
| Lindheimer, MD | 1 |
| Woodruff, TK | 1 |
| Knight, PG | 1 |
| Ledger, WL | 2 |
| Silver, HM | 1 |
| Lambert-Messerlian, GM | 1 |
| Star, JA | 1 |
| Hogan, J | 1 |
| Canick, JA | 1 |
| Laivuori, H | 1 |
| Kaaja, R | 1 |
| Turpeinen, U | 1 |
| Stenman, UH | 1 |
| Ylikorkala, O | 1 |
| D'Antona, D | 1 |
| Evans, LW | 1 |
| Morris, J | 1 |
| Schellenberg, JC | 2 |
| Asselin, J | 1 |
| Ledger, W | 1 |
| Grobman, WA | 1 |
| Wang, EY | 1 |
| Yair, D | 1 |
| Eshed-Englender, T | 1 |
| Kupferminc, MJ | 1 |
| Geva, E | 1 |
| Frenkel, J | 1 |
| Sherman, D | 1 |
| Taylor, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Is a History of Pre-eclampsia Before Systemic Sclerosis Onset a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?[NCT04363021] | 378 participants (Actual) | Observational | 2020-07-06 | Completed | |||
| Diagnostic Value of Calponin 2 in Identifying Tubal Pregnancies[NCT05591599] | 407 participants (Anticipated) | Observational | 2022-12-05 | Recruiting | |||
| Screening for Placental Insufficiency by a Combination of Second Trimester Uterine Artery Doppler and Maternal Serum Leptin and Lipids[NCT00465634] | 235 participants (Actual) | Observational | 2003-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for activins and Edema-Proteinuria-Hypertension Gestosis
| Article | Year |
|---|---|
Maternal Serum Activin A, Inhibin A and Follistatin-Related Proteins across Preeclampsia: Insights into Their Role in Pathogenesis and Prediction.
Topics: Activins; Female; Follistatin; Follistatin-Related Proteins; Humans; Inhibins; Pre-Eclampsia; Pregna | 2023 |
Activin signalling and pre-eclampsia: from genetic risk to pre-symptomatic biomarker.
Topics: Activins; Biomarkers; Clinical Trials as Topic; Cytokines; Female; Genetic Predisposition to Disease | 2015 |
Pulsatility index in combination with biomarkers or mean arterial pressure for the prediction of pre-eclampsia: Systematic literature review and meta-analysis.
Topics: Activins; Biomarkers; Blood Pressure; Female; Galectins; Humans; Inhibins; Placenta Growth Factor; P | 2015 |
Activins in reproductive biology and beyond.
Topics: Activins; Animals; Female; Follistatin; Glycoproteins; Humans; Inhibin-beta Subunits; Inhibins; Male | 2016 |
Novel biomarkers for predicting preeclampsia.
Topics: Activins; Angiogenesis Inducing Agents; Antigens, CD; Apolipoproteins E; Biomarkers; Endoglin; Femal | 2008 |
[Activin and activin receptors in related gynecologic and obstetric diseases].
Topics: Activin Receptors; Activins; Animals; Endometrial Neoplasms; Endometriosis; Female; Humans; Ovarian | 2010 |
Mutations in inhibin and activin genes associated with human disease.
Topics: Activins; Animals; Endocrine Gland Neoplasms; Female; Genital Neoplasms, Male; Humans; Inhibins; Mal | 2012 |
Biochemical screening for the prediction of preeclampsia.
Topics: Activins; Biomarkers; Female; Humans; Inhibin-beta Subunits; Inhibins; Leptin; Pre-Eclampsia; Pregna | 2005 |
Measurement of inhibin A and activin A in pregnancy--possible diagnostic applications.
Topics: Activins; Down Syndrome; Female; Humans; Inhibins; Obstetric Labor, Premature; Pre-Eclampsia; Pregna | 2001 |
1 trial available for activins and Edema-Proteinuria-Hypertension Gestosis
| Article | Year |
|---|---|
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.
Topics: Activins; Adult; Blood Flow Velocity; Female; Humans; Inhibin-beta Subunits; Inhibins; Laser-Doppler | 2003 |
54 other studies available for activins and Edema-Proteinuria-Hypertension Gestosis
| Article | Year |
|---|---|
Circulating Activin A is elevated at 36 weeks' gestation preceding a diagnosis of preeclampsia.
Topics: Activins; Adult; Biomarkers; Case-Control Studies; Female; Humans; Placenta; Pre-Eclampsia; Pregnanc | 2022 |
Activin A causes endothelial dysfunction of mouse aorta and human aortic cells.
Topics: Activins; Animals; Aorta; Endothelial Cells; Endothelium, Vascular; Female; Humans; Mice, Inbred C57 | 2022 |
Preeclampsia and Its Impact on Human Milk Activin A Concentration.
Topics: Activins; Breast Feeding; Female; Humans; Milk, Human; Pre-Eclampsia; Pregnancy | 2023 |
Role of Activin A in the Pathogenesis of Endothelial Cell Dysfunction in Preeclampsia.
Topics: Activins; Cells, Cultured; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Femal | 2018 |
Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2.
Topics: Activins; Antioxidants; Endothelial Cells; Female; Heme Oxygenase-1; Human Umbilical Vein Endothelia | 2017 |
Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies.
Topics: Activins; Animals; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Female; Humans; In Vit | 2015 |
In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
Topics: Activins; Angiogenic Proteins; Antigens, CD; Antihypertensive Agents; Chorionic Gonadotropin; Chorio | 2014 |
ACVR2A promoter polymorphism rs1424954 in the Activin-A signaling pathway in trophoblasts.
Topics: Activin Receptors, Type II; Activins; Alleles; Cell Line; Down-Regulation; Exons; Female; Gene Expre | 2015 |
Inhibition of activin A signalling in a mouse model of pre-eclampsia.
Topics: Activin Receptors; Activins; Animals; Disease Models, Animal; Female; Mice; Pre-Eclampsia; Pregnancy | 2015 |
Effects of normal and high circulating concentrations of activin A on vascular endothelial cell functions and vasoactive factor production.
Topics: Activin Receptors, Type II; Activins; Adult; Biomarkers; Cell Culture Techniques; Endothelium, Vascu | 2015 |
Role of activin A in the pathogenesis of endothelial cell dysfunction in preeclampsia.
Topics: Activins; Adult; Biomarkers; Case-Control Studies; Endothelin-1; Female; Human Umbilical Vein Endoth | 2016 |
Maternal circulating levels of transforming growth factor-β superfamily and its soluble receptors in hypertensive disorders of pregnancy.
Topics: Activins; Adult; Endoglin; Female; Humans; Hypertension, Pregnancy-Induced; Inhibins; Pre-Eclampsia; | 2017 |
Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Topics: Activins; Biomarkers; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Gestational A | 2008 |
Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.
Topics: Activins; Antigens, CD; Case-Control Studies; Endoglin; Female; Humans; Inhibins; Labor, Obstetric; | 2009 |
Maternal serum activin a at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
Topics: Activins; Adult; Case-Control Studies; Female; Gestational Age; Humans; Hypertension, Pregnancy-Indu | 2009 |
Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Topics: Activins; Adult; Biomarkers; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans | 2011 |
High levels of activin A detected in preeclamptic placenta induce trophoblast cell apoptosis by promoting nodal signaling.
Topics: Activin Receptors, Type I; Activins; Adult; Amino Acid Sequence; Apoptosis; Case-Control Studies; Ce | 2012 |
Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.
Topics: Activins; Biomarkers; Case-Control Studies; Female; Humans; Pre-Eclampsia; Predictive Value of Tests | 2013 |
Hypoxia inhibits activin A production by term villous trophoblast in vitro.
Topics: Activins; Cell Hypoxia; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Follistatin; Hum | 2002 |
Effect of hypoxia on placental activin A, inhibin A and follistatin synthesis.
Topics: Activins; Adult; Cell Hypoxia; Cells, Cultured; Cobalt; Endothelial Growth Factors; Endothelium, Vas | 2003 |
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Topics: Activins; Adolescent; Adult; alpha-Fetoproteins; Biomarkers; Case-Control Studies; Chorionic Gonadot | 2003 |
Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Topics: Activins; Adult; Female; Fetal Growth Retardation; Humans; Inhibin-beta Subunits; Inhibins; Placenta | 2002 |
Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Topics: Activins; Biomarkers; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Fetal Growth Retard | 2003 |
Maternal serum activin A is not elevated before preeclampsia in women who are at high risk.
Topics: Activins; Adult; Cohort Studies; Female; Forecasting; Humans; Hypertension; Inhibin-beta Subunits; P | 2003 |
Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin.
Topics: Activins; Adolescent; Adult; Biomarkers; Case-Control Studies; E-Selectin; Enzyme-Linked Immunosorbe | 2003 |
Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia.
Topics: Activin Receptors; Activins; Female; Follistatin; Gene Expression Regulation; Humans; Inhibins; Plac | 2003 |
Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Topics: Activins; Adult; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Enzyme-Linked Im | 2004 |
Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia.
Topics: Activins; Cells, Cultured; Endothelium, Vascular; Endotoxins; Escherichia coli; Female; Follistatin; | 2003 |
[Study on the relationship between activin A, follistatin and preeclampsia].
Topics: Activins; Adult; Female; Follistatin; Humans; Inhibin-beta Subunits; Pre-Eclampsia; Pregnancy; RNA, | 2003 |
[Inhibins and Activin A in hypertensive Disorders of Pregnancy and HELLP-Syndrome].
Topics: Activins; Female; HELLP Syndrome; Humans; Hypertension; Inhibin-beta Subunits; Inhibins; Pre-Eclamps | 2004 |
First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Topics: Activins; Case-Control Studies; Female; Fetal Growth Retardation; Humans; Inhibin-beta Subunits; Pre | 2004 |
Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry.
Topics: Activins; Adult; Biomarkers; Blood Flow Velocity; Female; Fibronectins; Humans; Inhibin-beta Subunit | 2005 |
Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Topics: Activins; Adult; alpha-Fetoproteins; Arteries; Blood Flow Velocity; Chorionic Gonadotropin; Estriol; | 2005 |
Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies.
Topics: Activins; Erythroblasts; Erythropoiesis; Erythropoietin; Female; Humans; Inhibin-beta Subunits; Plac | 2006 |
Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation.
Topics: Activins; Arteries; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Epidemiologic Methods; | 2006 |
Serum levels of activin A and inhibin A are not related to the increased susceptibility to pre-eclampsia in type I diabetic pregnancies.
Topics: Activins; Adult; Analysis of Variance; Chi-Square Distribution; Disease Susceptibility; Female; Huma | 2006 |
Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Topics: Activins; Adult; Analysis of Variance; Case-Control Studies; Catheterization, Peripheral; Female; Fo | 2006 |
Activin A, hypoxia and the prediction of obstetric outcomes.
Topics: Activins; Adult; Biomarkers; Case-Control Studies; Delivery, Obstetric; Female; Fetal Growth Retarda | 2006 |
[Inhibin/activin and pregnancy].
Topics: Activins; Animals; Biomarkers; Down Syndrome; Female; Fetal Diseases; Follistatin; Hydatidiform Mole | 2006 |
Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
Topics: Activins; Adult; Biomarkers; Creatinine; Female; Humans; Hypertension; Immunoassay; Inhibins; Pre-Ec | 2006 |
Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia.
Topics: Activins; Adult; Arteries; DNA; Enzyme-Linked Immunosorbent Assay; Female; Fetal Blood; Fetus; Human | 2006 |
Oxidative stress increases placental and endothelial cell activin A secretion.
Topics: Activins; Adult; Antioxidants; Ascorbic Acid; Case-Control Studies; Cells, Cultured; Endothelial Cel | 2007 |
Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
Topics: Activins; Adult; Biomarkers; Case-Control Studies; Female; Humans; Mothers; P-Selectin; Pre-Eclampsi | 2007 |
Hypertension in pregnancy: changes in activin A maternal serum concentration.
Topics: Activins; Adult; Animals; Case-Control Studies; Evaluation Studies as Topic; Female; Humans; Hyperte | 1995 |
Activin A, inhibin A, and pre-eclampsia.
Topics: Activins; Biomarkers; Female; Humans; Inhibins; Pre-Eclampsia; Pregnancy | 1997 |
Activin A and inhibin A as possible endocrine markers for pre-eclampsia.
Topics: Activins; Biomarkers; Chorionic Gonadotropin; Chromatography, Liquid; Cross-Sectional Studies; Femal | 1997 |
Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies.
Topics: Activins; Adult; Female; Gestational Age; Humans; Hypertension; Inhibins; Pre-Eclampsia; Pregnancy; | 1999 |
Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
Topics: Activins; Adult; Biomarkers; Female; Gestational Age; Humans; Inhibins; Insulin Resistance; Peptides | 1999 |
Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders.
Topics: Activins; Case-Control Studies; Female; Fetal Growth Retardation; Follistatin; Glycoproteins; Humans | 2000 |
Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia.
Topics: Activins; Adult; Case-Control Studies; Female; Gestational Age; Humans; Hypertension; Inhibins; Long | 2000 |
Serum levels of activin A and inhibin A and the subsequent development of preeclampsia.
Topics: Activins; Adolescent; Adult; Biomarkers; Female; Humans; Infant, Newborn; Inhibins; Pre-Eclampsia; P | 2000 |
Serum levels of inhibin B, unlike inhibin A and activin A, are not altered in women with preeclampsia.
Topics: Activins; Adult; Female; Humans; Inhibins; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Pro | 2001 |
Activin A and activin receptors in gestational tissue from preeclamptic pregnancies.
Topics: Activin Receptors; Activins; Case-Control Studies; Eclampsia; Extraembryonic Membranes; Female; Huma | 2001 |
Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies.
Topics: Activins; Adult; Blood Pressure; Case-Control Studies; Cross-Sectional Studies; Female; Fetal Growth | 2002 |